Is Nanjing Vazyme Biotech stock a buy?

Yes, Nanjing Vazyme Biotech pays dividends. Last time was Monday 8th of July 2024 where the investors holding the stock on Monday 8th of July 2024 were paid CNY0.1 per share. Over the last 3 times between 2022 and 2024, Nanjing Vazyme Biotech has paid CNY1.65 with an average of CNY0.55 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Nanjing Vazyme Biotech 10 years ago, but if you had invested on Monday 15th of November 2021 when the price was CNY85.35, you would have made a loss of CNY-66.17 per share or -77.53%

Yes, the average daily trading liquidity for Nanjing Vazyme Biotech is CNY1.21 million. You should therefore be able to get in and out of your positions relatively fast.

Nanjing Vazyme Biotech has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.19, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Nanjing Vazyme Biotech to be medium [0.6 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.